Recurrent sick leave and resignation rates among female cancer survivors after return to work: the Japan sickness absence and return to work (J-SAR) study
Open Access
- 11 September 2019
- journal article
- research article
- Published by Springer Nature in BMC Public Health
- Vol. 19 (1) , 1-8
Abstract
Background: To date, there have not been any workforce-based Japanese cohort studies investigating work sustainability after return to work (RTW). The objective of this study was to investigate the post-RTW cumulative recurrent sick leave rate and cumulative resignation rate among female cancer survivors.Methods: Among Japanese employees who were registered in the Japan sickness absence and return to work (J-SAR) study, the subjects were those female employees who returned to work after sick leave due to newly clinically diagnosed cancer (C01-C99; ICD-10), based on a physician’s certificate, between 2000 and 2011. The last day of the follow-up period was December 31, 2012. The recurrent sickness leave rate and resignation rate were calculated using competing risk survival analysis.Results: Of 223 cancer survivors, 61 took further physician-certified sick leave after their RTW. The median duration of the post-RTW work period among all cancer survivors was 10.6 years. The work continuance rates of the female cancer survivors were 83.2 and 60.4% at 1 and 5 years after they returned to work, respectively. There was a steep reduction in the work continuance rate during the first post-RTW year. There were considerable differences in the work continuance rate according to the primary cancer site. Cumulative recurrent sick leave rates of 11.8 and 28.9% were seen at 1 and 5 years after the subjects returned to work. The cumulative resignation rate was 5.0 and 10.7% at 1 and 5 years after the subjects returned to work. Most recurrent sick leave occurred in the first year after the subjects returned to work, followed by the second year.Conclusions: Sixty percent of female cancer survivors were still working at 5 years after returning to work, although the work continuance rates for different types of cancer varied significantly.Keywords
Funding Information
- Japanese Ministry of Health, Labour and Welfare (Research Grant (Gan-taisaku-ippan-012)
This publication has 38 references indexed in Scilit:
- Investigation of the freely available easy-to-use software ‘EZR’ for medical statisticsBone Marrow Transplantation, 2012
- Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: a cross-sectional studyBMJ Open, 2011
- Sickness absence and full return to work after cancer: 2‐year follow‐up of register data for different cancer sitesPsycho-Oncology, 2011
- Impact of breast cancer diagnosis and treatment on work-related life and factors affecting themBreast Cancer Research and Treatment, 2008
- Work ability and return-to-work in cancer patientsBritish Journal of Cancer, 2008
- Work disability associated with cancer survivorship and other chronic conditionsPsycho-Oncology, 2007
- Recent cancer survival in Europe: a 2000–02 period analysis of EUROCARE-4 dataThe Lancet Oncology, 2007
- A controlled study of job strain in primary-treated cancer patients without metastasesActa Oncologica, 2007
- A comparative study of living conditions in cancer patients who have returned to work after curative treatmentSupportive Care in Cancer, 2006
- Return to work of cancer survivors: a prospective cohort study into the quality of rehabilitation by occupational physiciansOccupational and Environmental Medicine, 2003